ERMAP Activators
ERMAP activators encompass a variety of chemical compounds that indirectly stimulate the functional activity of ERMAP through multiple signaling pathways intricately connected to red blood cell development and morphology. For instance, compounds like Epinephrine and Isoproterenol raise intracellular cAMP levels, activating PKA, which is known to phosphorylate proteins that could be in pathways intersecting with those ERMAP functions within, thus enhancing the maturation process of erythroid cells. Similarly, Forskolin and IBMX increase cAMP through direct activation of adenylyl cyclase and inhibition of cAMP degradation, respectively, propagating a cascadethat culminates in PKA activation which may, in turn, influence ERMAP's role in the erythroblast differentiation. The involvement of ERMAP in shaping erythrocyte structure is further supported by the actions of PMA, a potent PKC activator, which could lead to phosphorylation events within the erythrocyte membrane remodeling complex, possibly enhancing the structural integrity of red blood cells mediated by ERMAP.
Further emphasizing the diverse mechanisms of ERMAP activation, Ionomycin and Thapsigargin elevate intracellular calcium, affecting calcium-dependent kinases, which may have a role in the pathways where ERMAP is active, thereby influencing erythrocyte membrane dynamics. The use of db-cAMP and A23187 also center around modulating intracellular messengers such as cAMP and calcium, respectively, to indirectly promote ERMAP's role in red blood cell development. Additionally, the nitric oxide donor SNAP and Sildenafil act on the nitric oxide and cGMP pathways to enhance ERMAP's function in maintaining erythrocyte flexibility, which is crucial for preventing red blood cell aggregation. Lastly, Y-27632 serves as a ROCK inhibitor, which could induce changes in cytoskeletal dynamics; since ERMAP is associated with the erythrocyte membrane, such alterations might enhance ERMAP's function in maintaining membrane stability, an essential aspect of red blood cell physiology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, by binding to adrenergic receptors, can increase intracellular cAMP levels, which subsequently activates PKA. PKA can phosphorylate proteins within the same signaling pathways as ERMAP, potentially enhancing ERMAP's activity in erythroblast differentiation or influencing erythrocyte shape and structure. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, elevates cAMP levels and activates PKA, which could enhance ERMAP activity indirectly by influencing signaling pathways related to erythroid cell maturation where ERMAP is a key participant. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly activates adenylyl cyclase, leading to an increase in cAMP concentration and activation of PKA. PKA can then modulate proteins that interact with ERMAP, enhancing its functional activity in red blood cell development. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which increases cAMP by preventing its degradation, thereby activating PKA. This activation could enhance ERMAP function in its role within erythrocyte morphology and integrity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC), which may phosphorylate substrates that are part of the erythrocyte membrane remodeling complex, potentially enhancing ERMAP's role in this process. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, which can activate calcium-dependent kinases that may augment ERMAP activity indirectly by altering the erythrocyte membrane structures. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels, which could enhance ERMAP activity by affecting calcium-dependent pathways within red blood cells. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analogue that activates PKA. PKA activation could enhance ERMAP's function in red blood cell development and maintenance by influencing downstream signaling mechanisms. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
Nitric oxide donors like S-Nitroso-N-Acetyl-DL-Penicillamine (SNAP) can lead to the activation of soluble guanylyl cyclase, increasing cGMP levels, which could enhance ERMAP's activity in modulating red blood cell flexibility and reducing aggregability. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium levels. This increase can activate signaling pathways in which ERMAP may be involved, leading to enhanced activity in erythrocyte formation and membrane stability. | ||||||